KINIKSA PHARMACEUTICALS LTD's ticker is and the CUSIP is G5269C901. A total of 3 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $140,320 | -87.5% | 8,000 | -87.6% | 0.00% | -100.0% |
| Q3 2023 | $1,122,102 | +28.3% | 64,600 | +4.0% | 0.00% | +33.3% |
| Q2 2023 | $874,368 | -20.6% | 62,100 | -39.3% | 0.00% | -25.0% |
| Q1 2023 | $1,100,748 | -28.0% | 102,300 | +0.3% | 0.00% | 0.0% |
| Q4 2022 | $1,527,960 | +141.4% | 102,000 | +106.9% | 0.00% | +300.0% |
| Q3 2022 | $633,000 | -7.9% | 49,300 | -30.5% | 0.00% | 0.0% |
| Q2 2022 | $687,000 | +467.8% | 70,900 | +481.1% | 0.00% | – |
| Q1 2022 | $121,000 | -72.6% | 12,200 | -67.5% | 0.00% | – |
| Q4 2021 | $441,000 | -47.1% | 37,500 | -48.8% | 0.00% | -100.0% |
| Q3 2021 | $834,000 | +631.6% | 73,200 | +792.7% | 0.00% | – |
| Q2 2021 | $114,000 | -47.7% | 8,200 | -30.5% | 0.00% | – |
| Q1 2021 | $218,000 | +142.2% | 11,800 | +131.4% | 0.00% | – |
| Q4 2020 | $90,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 28 | $42,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |